A decrease in anaerobic bacteria promotes Candida glabrata overgrowth while β-glucan treatment restores the gut microbiota and attenuates colitis

BackgroundThe intestinal microbiota plays a crucial role in the maintenance of gut homeostasis. Changes in crosstalk between the intestinal epithelial cells, immune cells and the microbiota are critically involved in the development of inflammatory bowel disease. In the experimental mouse model, the development of colitis induced by dextran sulfate sodium (DSS) promotes overgrowth of the opportunistic yeast pathogen Candida glabrata. Conversely, fungal colonization aggravates inflammatory parameters. In the present study, we explored the effect of C. glabrata colonization on the diversity of the gut microbiota in a DSS-induced colitis model, and determined the impact of soluble -glucans on C. glabrata-host interactions.ResultsMice were administered a single inoculum of C. glabrata and were exposed to DSS treatment for 2weeks in order to induce acute colitis. For -glucan treatment, mice were administered with soluble -glucans purified from C. glabrata (3mg per mouse), orally and daily, for 5days, starting on day 1. The number of C. glabrata colonies and changes in microbiota diversity were assessed in freshly collected stool samples from each tagged mouse, using traditional culture methods based on agar plates. An increase in Escherichia coli and Enterococcus faecalis populations and a reduction in Lactobacillus johnsonii and Bacteroides thetaiotaomicron were observed during colitis development. This decrease in L. johnsonii was significantly accentuated by C. glabrata overgrowth. Oral administration of -glucans to mice decreased the overgrowth of aerobic bacteria and IL-1 expression while L. johnsonii and B. thetaiotaomicron populations increased significantly. -glucan treatment increased IL-10 production via PPAR sensing, promoting the attenuation of colitis and C. glabrata elimination.ConclusionsThis study shows that the colonic inflammation alters the microbial balance, while -glucan treatment increases the anaerobic bacteria and promotes colitis attenuation and C. glabrata elimination.